RBI conducts VRR auctions to ease liquidity tightness in banking system, with system liquidity deficit widening.

Dr. Reddy's Laboratories shares fell by 6.2% after the company reported a marginal 2% YoY growth in Q3 FY25 net profit to Rs 1,413 crore. Despite robust revenue growth, Jefferies, Nuvama, and DAM ...

Infra.Market: The round witnessed participation from several prominent investors, including Tiger Global, Evolvence, Foundamental GmbH, Ashish Kacholia, Nikhil Kamath, Abhijit Pai, Sumeet Kanwar, ...

Revlimid, which has arguably been the single biggest growth driver for Dr Reddy's in recent years, is set to go off patent in ...

Nuvama slashed its FY25 and 26 EPS estimates by 10.8 per cent and 4.5 per cent, respectively, on lower growth and margins. It suggested a revised target price of Rs 1,660 from Rs 1,700 earlier.

Goldman Sachs reportedly has maintained a 'Buy' rating and increased its target price to Rs 12,580, up from Rs 12,460, citing volume recovery and lower costs contributing to margin improvement ...

Coforge’s strong performance in Q3 and solid TCV set up the base perfectly for 20 per cent-plus YoY growth in FY26, Nuvama said. Besides, margin expansion on lower ESOP costs should yield 25 per ...

IndiGo’s net profit is expected to fall 34% to ₹1,974 crore in Q3FY25 from ₹2,998.1 crore YoY. The company posted a net loss of ₹986.7 crore in the previous quarter.

The company has partnered with Kotak Mahindra Capital, IIFL Capital, Goldman Sachs, Jefferies, ICICI Securities, HSBC Securities, Motilal Oswal Financial Services, and Nuvama Wealth Management, to ...

With rates on fixed deposits going up over the past one year, HDFC Bank has seen a moderation in the CASA ratio.

The fundraise comes less than a year after it raised about $50 million from Mars Unicorn Fund at a valuation of $2.5 billion.